Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Fiche publication
Date publication
janvier 2017
Journal
Annals of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles, Pr GRAESSLIN Olivier
Tous les auteurs :
Ouldamer L, Bendifallah S, Body G, Canlorbe G, Touboul C, Graesslin O, Raimond E, Collinet P, Coutant C, Lavoué V, Lévêque J, Daraï E, Ballester M,
Lien Pubmed
Résumé
The European Society of Medical Oncology (ESMO)/European Society of Gynaecological Oncology (ESGO)/European Society for Radiotherapy & Oncology (ESTRO) classification for endometrial cancer (EC) now includes a high-intermediate risk (HIR) group of recurrence due to the adverse prognostic role of lymphovascular space involvement (LVSI) and grade 3 for women at intermediate risk. However, optimal surgical staging, and especially the place of lymphadenectomy, remains to be elucidated. We aimed to establish whether systematic nodal staging should be part of surgical staging for women with HIR EC.
Mots clés
Adult, Aged, Aged, 80 and over, Endometrial Neoplasms, pathology, Female, Follow-Up Studies, Humans, Lymph Node Excision, Lymphatic Metastasis, Medical Oncology, Middle Aged, Neoplasm Invasiveness, Neoplasm Recurrence, Local, pathology, Neoplasm Staging, Prospective Studies, Risk Factors, Sentinel Lymph Node Biopsy, Societies, Medical, Survival Rate
Référence
Ann. Surg. Oncol.. 2017 Jan;: